Advertisement
This payment represents a continuation of the current rate, which wasincreased earlier this year by 30 percent. This quarterly dividend is payableon October 1, 2008 to shareholders of record as of September 10, 2008.
Advertisement
Baxter International Inc. develops, manufactures and markets products thatsave and sustain the lives of people with hemophilia, immune disorders,cancer, infectious diseases, kidney disease, trauma, and other chronic andacute medical conditions. As a global, diversified healthcare company, Baxterapplies a unique combination of expertise in medical devices, pharmaceuticalsand biotechnology to create products that advance patient care worldwide.
SOURCE Baxter International Inc.
